Funding

Convener: FUNDACION BBVA

7 funding - 658,336€

data available since 2018

2023

Immune cell recruiters as novel bispecific constructs to maximize immune cell entrance into the tumors.
40,000.00

2022

Plataforma de cribado de moléculas inmunoestimulantes bifuncionales para tratamiento personalizado del cáncer renal
40,000.00
Identification of the epigenomic and transcriptomic alterations in the transformation of benign monoclonal gammapathies to symptomatic multiple myeloma.
149,985.00

2020

MINCITH. Metabolic requirements for immune INfiltration in effective Cancer ImmunoTHerapy.
124,768.00
LUng MAcrophage involvement in Lethal COVID-19 pathogenesis: an immunopathology approach to Actionable Mechanisms - LUMACOVID
201,828.00
Dinámicas de difusión en redes sociales de noticias falsas sobre salud [RRSSalud]
61,755.00

2018

Terapia personalizada para Cáncer de Pulmón con distinto paisaje mutacional mediante cultivos 3D de organoides
40,000.00